CN105709010A - Pharmaceutical composition having blood-sugar reducing assisting function - Google Patents
Pharmaceutical composition having blood-sugar reducing assisting function Download PDFInfo
- Publication number
- CN105709010A CN105709010A CN201410734899.XA CN201410734899A CN105709010A CN 105709010 A CN105709010 A CN 105709010A CN 201410734899 A CN201410734899 A CN 201410734899A CN 105709010 A CN105709010 A CN 105709010A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- powder
- auxiliary hyperglycemic
- hyperglycemic function
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a pharmaceutical composition having a blood-sugar reducing assisting function, and belongs to the field of a compound traditional Chinese medicinal preparation. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 20-40 parts of bark of eucommia, 15-25 parts of herba cistanches, 15-25 parts of rhizoma dioscoreae, 10-20 parts of herba centellae, 10-20 parts of fructus momordicae, 10-20 parts of fructus gardenia, 5-15 parts of lotus leaf and 5-15 parts of leaf of Chinese wolfberry. The pharmaceutical composition disclosed by the invention is capable of effectively reducing blood sugar; and the pharmaceutical composition has the characteristics of being rapid to take effect, good in curative effect and free from toxic and side effects.
Description
Technical field
The present invention relates to compound Chinese medicinal preparation field, especially relate to a kind of pharmaceutical composition with auxiliary hyperglycemic function.
Background technology
Diabetes are by inherited genetic factors, immunologic function disorder, microorganism infection and the multiple virulence factor such as toxin and Nervous and Mental Factors thereof act on body, cause hypoinsulinism, insulin resistant etc. and cause sugar, protein, fat, a series of metabolism disorder syndromes such as power and water Xie Zhi, it it is the commonly encountered diseases currently endangering human health, become the 5th the dead killer of the mankind, show as weight loss, fatigue and weak and easily hungry polyphagia, it is susceptible to cardiovascular, cerebrovascular, kidney, eye ground and neural chronic disease, even cause blind and disable, have a strong impact on health and work, viability.
International Diabetes Federation's recent statistics data in 2009 display whole world diabetics has reached 2.85 hundred million, wherein more than half patient age between 20-60 year between.The existing diabetics of China about 43,200,000, is only second to India (50,800,000), occupies second place of the world.Growth rate accordingly, the year two thousand thirty whole world diabetics sum will more than 4.35 hundred million.Currently, the whole world there are about 4,000,000 people every year and dies from diabetes.It addition, diabetes are again the one of the main reasons causing blind, renal failure, heart disease, apoplexy and amputation.
Owing to the cause of disease and the pathogenesis of diabetes are not yet fully apparent from, therefore also lack effective causative treatments at present.To the treatment of diabetes, adopting insulin treatment and oral hypoglycemic drug therapy clinically now more, but diabetes spp is in a kind of lifelong participation disease, need long-term prescription, the drug administration by injection method of insulin often brings much inconvenience to patient, and the orally-taken blood sugar reducing medicine that clinic is commonly used belongs to chemical drugs more, long-term taking also can cause a series of untoward reaction.
In view of the presence of problem above, utilize the advantage that Chinese traditional herbs treatment diabetes are gentle persistently, side effect is little, develop a kind of safely, effectively, be suitable to the hypoglycemic drug market of long-term taking is badly in need of very much.
Summary of the invention
The goal of the invention of the present invention is in that: for above-mentioned Problems existing, it is provided that a kind of pharmaceutical composition with auxiliary hyperglycemic function, and the present invention can effectively reduce blood glucose, has instant effect, good effect and the feature having no side effect.
For achieving the above object, the technical solution used in the present invention is as follows:
A kind of pharmaceutical composition with auxiliary hyperglycemic function, is made up of the raw material of following weight portion: the Cortex Eucommiae 20～40 parts, Herba Cistanches 15～25 parts, Rhizoma Dioscoreae 15～25 parts, Herba Centellae 10～20 parts, Fructus Momordicae 10～20 parts, Fructus Gardeniae 10～20 parts, 5～15 parts of Folium Nelumbinis, Folium Lycii 5～15 parts.
It is further preferred that described in there is the pharmaceutical composition of auxiliary hyperglycemic function be in that to be made up of the raw material of following weight portion: the Cortex Eucommiae 25～30 parts, Herba Cistanches 20～25 parts, Rhizoma Dioscoreae 18～25 parts, Herba Centellae 15～18 parts, Fructus Momordicae 16～20 parts, Fructus Gardeniae 12～15 parts, 8～12 parts of Folium Nelumbinis, Folium Lycii 6～12 parts.
The preparation method that the present invention also provides for above-mentioned a kind of pharmaceutical composition with auxiliary hyperglycemic function, comprises the following steps:
Step one, dries dry for above-mentioned eight tastes Chinese herbal medicine 2～4 hours at 50～60 DEG C respectively respectively, crosses 80～120 mesh sieves, by weight ratio eight taste herbal powder mix homogeneously are obtained thick medicated powder after pulverizing respectively；
Step 2, is broken to, by the thick medicated powder fine powder of step one, the super fine that particle diameter is 5～20 μm；
Step 3, the super fine of step 2 is dried, obtain finished product through sterilization encapsulation.
It is further preferred that finished product is any one in powder, pill, tablet, capsule, unguentum, liquor in described step 3.
Consumption: be grown up each 10g, every day 3 times.
In sum, owing to have employed technique scheme, the invention has the beneficial effects as follows:
1, the eight taste Chinese herbal medicine that the present invention is selected have excellent moisturizing promoting the circulation of QI, clearing away heat-fire, promote the production of body fluid and the effect such as moisturize, the ubiquitous irritated weak phenomenon of diabetes patient can be improved after reasonably composite, thus playing hypoglycemic effect, it is tracked investigation by more than 60 patients are used, after the present invention eight hypoglycemic pharmaceutical composition of taste is taken in discovery, hypoglycemic effect is obvious, diabetics below general light moderate, drinks three months continuously, and effective percentage reaches more than 90%.
2, prescription Chinese medicine of the present invention is prepared into fine powder, by a certain percentage after mixing, boiled water is taken after mixing it with water, or add in beverage, milk, coffee, gruel to stir evenly and take, can also make in powder, pill, tablet, capsule, unguentum, liquor any one, avoid the inconvenience that Chinese medicine decocts, do not result in again the loss of effective ingredient in decoction process.The present invention can be effectively improved the symptoms such as diabetics hyperglycemia, hemorheology and dyslipidemia, has treating both the principal and secondary aspects of a disease, effect is notable, have no side effect, carry the features such as easy to use., confirming through clinical case, to prevention hyperlipidemia, hypertension, improving body immunity, delaying senility course also has notable effectiveness meanwhile.
3, the preparation technology of this pharmaceutical composition, adopt pulverizes, sieve, dry, the operation such as stirring prepares finished product, all process steps is Physical Processing program, the maximum reservation original effect of medicine.
Detailed description of the invention
By the following examples, the invention will be further described.The invention is not limited in following detailed description of the invention.The present invention expands to any new feature disclosed in this manual or any new combination, and the step of the arbitrary new method disclosed or process or any new combination.
Embodiment 1
A kind of pharmaceutical composition with auxiliary hyperglycemic function, is made up of the raw material of following weight portion: the Cortex Eucommiae 20 parts, Herba Cistanches 15 parts, Rhizoma Dioscoreae 15 parts, Herba Centellae 10 parts, Fructus Momordicae 10 parts, Fructus Gardeniae 10 parts, 5 parts of Folium Nelumbinis, Folium Lycii 5 parts.
A kind of pharmaceutical composition with auxiliary hyperglycemic function of the present invention makes as steps described below:
Step one, dries dry for above-mentioned eight tastes Chinese herbal medicine 2 hours at 50 DEG C respectively respectively, crosses 80 mesh sieves, by weight ratio eight taste herbal powder mix homogeneously are obtained thick medicated powder after pulverizing respectively
Step 2, is broken to, by the thick medicated powder fine powder of step one, the super fine that particle diameter is 5 μm；
Step 3, the super fine of step 2 is dried, after sterilization, make powder or capsule, encapsulation obtains finished product.
Embodiment 2
A kind of pharmaceutical composition with auxiliary hyperglycemic function, is made up of the raw material of following weight portion: the Cortex Eucommiae 25 parts, Herba Cistanches 20 parts, Rhizoma Dioscoreae 18 parts, Herba Centellae 15 parts, Fructus Momordicae 16 parts, Fructus Gardeniae 12 parts, 8 parts of Folium Nelumbinis, Folium Lycii 6 parts.
A kind of pharmaceutical composition with auxiliary hyperglycemic function of the present invention makes as steps described below:
Step one, dries dry for above-mentioned eight tastes Chinese herbal medicine 4 hours at 60 DEG C respectively respectively, crosses 120 mesh sieves, by weight ratio eight taste herbal powder mix homogeneously are obtained thick medicated powder after pulverizing respectively；
Step 2, is broken to, by the thick medicated powder fine powder of step one, the super fine that particle diameter is 20 μm；
Step 3, the super fine of step 2 is dried, after sterilization, make tablet or pill, encapsulation obtains finished product.
Embodiment 3
A kind of pharmaceutical composition with auxiliary hyperglycemic function, is made up of the raw material of following weight portion: the Cortex Eucommiae 40 parts, Herba Cistanches 25 parts, Rhizoma Dioscoreae 25 parts, Herba Centellae 20 parts, Fructus Momordicae 20 parts, Fructus Gardeniae 20 parts, 15 parts of Folium Nelumbinis, Folium Lycii 15 parts.
A kind of pharmaceutical composition with auxiliary hyperglycemic function of the present invention makes as steps described below:
Step one, dries dry for above-mentioned eight tastes Chinese herbal medicine 3 hours at 55 DEG C respectively respectively, crosses 100 mesh sieves, by weight ratio eight taste herbal powder mix homogeneously are obtained thick medicated powder after pulverizing respectively
Step 2, is broken to, by the thick medicated powder fine powder of step one, the super fine that particle diameter is 10 μm；
Step 3, the super fine of step 2 is dried, after sterilization, make liquor, encapsulation obtains finished product.
Embodiment 4
A kind of pharmaceutical composition with auxiliary hyperglycemic function, is made up of the raw material of following weight portion: the Cortex Eucommiae 30 parts, Herba Cistanches 25 parts, Rhizoma Dioscoreae 25 parts, Herba Centellae 18 parts, Fructus Momordicae 20 parts, Fructus Gardeniae 15 parts, 12 parts of Folium Nelumbinis, Folium Lycii 12 parts.
A kind of pharmaceutical composition with auxiliary hyperglycemic function of the present invention makes as steps described below:
Step one, dries dry for above-mentioned eight tastes Chinese herbal medicine 3 hours at 60 DEG C respectively respectively, crosses 120 mesh sieves, by weight ratio eight taste herbal powder mix homogeneously are obtained thick medicated powder after pulverizing respectively；
Step 2, is broken to, by the thick medicated powder fine powder of step one, the super fine that particle diameter is 15 μm；
Step 3, the super fine of step 2 is dried, after sterilization, make unguentum, encapsulation obtains finished product.
Claims (4)
1. a pharmaceutical composition with auxiliary hyperglycemic function, it is characterised in that be made up of the raw material of following weight portion: the Cortex Eucommiae 20～40 parts, Herba Cistanches 15～25 parts, Rhizoma Dioscoreae 15～25 parts, Herba Centellae 10～20 parts, Fructus Momordicae 10～20 parts, Fructus Gardeniae 10～20 parts, 5～15 parts of Folium Nelumbinis, Folium Lycii 5～15 parts.
2. a kind of pharmaceutical composition with auxiliary hyperglycemic function according to claim, it is characterised in that be made up of the raw material of following weight portion: the Cortex Eucommiae 25～30 parts, Herba Cistanches 20～25 parts, Rhizoma Dioscoreae 18～25 parts, Herba Centellae 15～18 parts, Fructus Momordicae 16～20 parts, Fructus Gardeniae 12～15 parts, 8～12 parts of Folium Nelumbinis, Folium Lycii 6～12 parts.
3. the preparation method of a kind of pharmaceutical composition with auxiliary hyperglycemic function described in the claims, it is characterised in that comprise the following steps:
Step one, dries dry for above-mentioned eight tastes Chinese herbal medicine 2～4 hours at 50～60 DEG C respectively respectively, crosses 80～120 mesh sieves, by weight ratio eight taste herbal powder mix homogeneously are obtained thick medicated powder after pulverizing respectively；
Step 2, is broken to, by the thick medicated powder fine powder of step one, the super fine that particle diameter is 5～20 μm；
Step 3, the super fine of step 2 is dried, obtain finished product through sterilization encapsulation.
4. the preparation method of a kind of pharmaceutical composition with auxiliary hyperglycemic function as claimed in claim 3, it is characterised in that: in described step 3, finished product is any one in powder, pill, tablet, capsule, unguentum, liquor.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410734899.XA CN105709010A (en) | 2014-12-05 | 2014-12-05 | Pharmaceutical composition having blood-sugar reducing assisting function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410734899.XA CN105709010A (en) | 2014-12-05 | 2014-12-05 | Pharmaceutical composition having blood-sugar reducing assisting function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105709010A true CN105709010A (en) | 2016-06-29 |
Family
ID=56144060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410734899.XA Pending CN105709010A (en) | 2014-12-05 | 2014-12-05 | Pharmaceutical composition having blood-sugar reducing assisting function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105709010A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110236195A (en) * | 2019-07-05 | 2019-09-17 | 青海瑞湖生物资源开发有限公司 | A kind of health food and preparation method thereof with auxiliary hyperglycemic function |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1620883A (en) * | 2004-12-30 | 2005-06-01 | 桂林莱茵生物科技股份有限公司 | Grosvenor momordica pouched tea |
| CN103690783A (en) * | 2013-12-25 | 2014-04-02 | 大连民族学院 | Chinese herba preparation for treating diabetes and preparation method of Chinese herba preparation |
| CN103992924A (en) * | 2014-06-04 | 2014-08-20 | 邵阳市金台酒厂 | Health-care juice wine for enhancing body immunity and manufacturing method thereof |
-
2014
- 2014-12-05 CN CN201410734899.XA patent/CN105709010A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1620883A (en) * | 2004-12-30 | 2005-06-01 | 桂林莱茵生物科技股份有限公司 | Grosvenor momordica pouched tea |
| CN103690783A (en) * | 2013-12-25 | 2014-04-02 | 大连民族学院 | Chinese herba preparation for treating diabetes and preparation method of Chinese herba preparation |
| CN103992924A (en) * | 2014-06-04 | 2014-08-20 | 邵阳市金台酒厂 | Health-care juice wine for enhancing body immunity and manufacturing method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110236195A (en) * | 2019-07-05 | 2019-09-17 | 青海瑞湖生物资源开发有限公司 | A kind of health food and preparation method thereof with auxiliary hyperglycemic function |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103566350B (en) | A kind of pharmaceutical composition with hypoglycemic effect | |
| CN102271698A (en) | Pharmaceutical composition and use for preparing medicament thereof | |
| CN103127232A (en) | Total extract for mulberry leaf prescription as well as preparation and usage thereof | |
| CN105341893A (en) | Composition for assisting in reducing blood glucose and application | |
| CN101085039B (en) | Composition for preventing and treating diabetes (hyperglycaemia) and its preparation method | |
| CN104398771B (en) | A kind of Chinese medicine composition for treating diabetes | |
| CN105935374A (en) | Application of Quanmasu in preparation of drugs for treatment of diabetes | |
| CN104324244A (en) | Compound dendrobium candidum blood-glucose-reducing capsule | |
| CN102488838A (en) | Traditional Chinese medicine composition used for treating viral myocarditis | |
| CN101618131A (en) | Chinese medicinal compound preparation for treating coronary heart disease and angina | |
| CN105709010A (en) | Pharmaceutical composition having blood-sugar reducing assisting function | |
| CN101019926A (en) | Chinese medicine for treating cardiac and cerebral vascular diseases and its prepn process | |
| CN113476561A (en) | Traditional Chinese medicine formula for treating diabetes | |
| CN102293855A (en) | Chinese medicinal composition for treating speech and kidney deficiency diabetic nephropathy, and preparation method and application thereof | |
| CN105770005A (en) | Preparation method for fresh portulaca oleracea and mulberry leaf low-temperature extract compound preparation for reducing blood sugar | |
| CN101884723A (en) | Anemarrhena and goldthread composition preparation used for treating diabetes and preparation method thereof | |
| CN102631492B (en) | Chinese medicinal composition for improving immunity and resisting fatigue | |
| CN1927289A (en) | Pharmaceutical composition for treating diabetes and impaired glucose tolerance and its preparation | |
| CN105521262A (en) | Healthcare food capable of assisting in blood sugar decrease and preparation method of healthcare food capable of assisting in blood sugar decrease | |
| CN104922445B (en) | A kind of Traditional Chinese medicine compound composition and the preparation method and application thereof with treatment heart failure effect | |
| CN104524359B (en) | A kind of Chinese medicine composition, its preparation method and application | |
| CN103989940A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN106038666A (en) | Bitter melon leaf extract and application thereof | |
| CN104904948A (en) | Hmong's health tea | |
| CN104825784B (en) | A kind of Chinese medicine composition with anti-gastric cancer activity and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160629 |